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ABSTRACT
Background
Little is known about the long-term safety of infant feeding interventions aimed at reducing
breast milk HIV transmission in Africa.
Methods and Findings
In 2001–2005, HIV-infected pregnant women having received in Abidjan, Co ˆte d’Ivoire, a
peripartum antiretroviral prophylaxis were presented antenatally with infant feeding
interventions: either artificial feeding, or exclusive breast-feeding and then early cessation
from 4 mo of age. Nutritional counseling and clinical management were provided for 2 y.
Breast-milk substitutes were provided for free. The primary outcome was the occurrence of
adverse health outcomes in children, defined as validated morbid events (diarrhea, acute
respiratory infections, or malnutrition) or severe events (hospitalization or death). Hazards ratios
to compare formula-fed versus short-term breast-fed (reference) children were adjusted for
confounders (baseline covariates and pediatric HIV status as a time-dependant covariate). The
18-mo mortality rates were also compared to those observed in the Ditrame historical trial,
which was conducted at the same sites in 1995–1998, and in which long-term breast-feeding
was practiced in the absence of any specific infant feeding intervention. Of the 557 live-born
children, 262 (47%) were breast-fed for a median of 4 mo, whereas 295 were formula-fed. Over
the 2-y follow-up period, 37% of the formula-fed and 34% of the short-term breast-fed children
remained free from any adverse health outcome (adjusted hazard ratio [HR]: 1.10; 95%
confidence interval [CI], 0.87–1.38; p ¼ 0.43). The 2-y probability of presenting with a severe
event was the same among formula-fed (14%) and short-term breast-fed children (15%)
(adjusted HR, 1.19; 95% CI, 0.75–1.91; p¼0.44). An overall 18-mo probability of survival of 96%
was observed among both HIV-uninfected short-term and formula-fed children, which was
similar to the 95% probability observed in the long-term breast-fed ones of the Ditrame trial.
Conclusions
The 2-y rates of adverse health outcomes were similar among short-term breast-fed and
formula-fed children. Mortality rates did not differ significantly between these two groups and,
after adjustment for pediatric HIV status, were similar to those observed among long-term
breast-fed children. Given appropriate nutritional counseling and care, access to clean water,
and a supply of breast-milk substitutes, these alternatives to prolonged breast-feeding can be
safe interventions to prevent mother-to-child transmission of HIV in urban African settings.
The Editors’ Summary of this article follows the references.
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In high human immunodeﬁciency virus (HIV) prevalence
resource-constrained settings, HIV-infected pregnant women
face a dilemma regarding the feeding practices of their
forthcoming infant [1]. Indeed, in sub-Saharan Africa, where
breast-feeding is widely practiced and usually prolonged at
least 1 y after birth, the overall risk of HIV transmission
through breast milk was estimated to be 8.9 new cases per 100
child-years of breast-feeding [2], and was thus responsible for
40% of perinatally acquired HIV infections [3]. On the other
hand, in the absence of any speciﬁc nutritional counseling
and adapted clinical management, nonbreast-fed children
have a greater risk of dying from infectious diseases,
especially early in infancy [4].
Current United Nations recommendations state that
‘‘when replacement feeding is acceptable, feasible, affordable,
sustainable and safe, avoidance of all breast-feeding by HIV-
infected mothers is recommended. Otherwise, exclusive
breast-feeding is recommended during the ﬁrst months of
life and should then be discontinued as soon as it is feasible’’
[5]. Given the necessary support, complete avoidance of
breast-feeding or exclusive breast-feeding with early cessa-
tion are conceivable nutritional interventions in urban
African settings [6]. According to several African studies,
the combined promotion of exclusivity of breast-feeding with
early cessation could indeed reduce the cumulative risk of
postnatal transmission while keeping the beneﬁts of breast-
feeding during the ﬁrst months of life [7–10]. On the other
hand, the postnatal risk of HIV transmission no longer exists
when breast-feeding exposure is avoided [11].
However, little is known about the safety of these
interventions. Compared to unrestricted breast-feeding,
complete avoidance of breast-feeding was shown to be safe
in an African clinical trial allocating infant feeding practices
at random: morbidity and mortality were similar over a span
of 2 y in breast-fed and formula-fed children [12]. But so far,
child morbidity and mortality have never been studied in
real-life situations in which HIV-infected pregnant women
are able to choose either to breast-feed for a short period or
to formula-feed, while being supported in their choice and
counseled accordingly.
The primary objective of this study was to assess the 2-y
morbidity and mortality among short-term breast-fed and
formula-fed children born to HIV-infected mothers in an
urban West African setting with access to clean water. The
secondary objective was to assess the 18-mo mortality among
children exposed to these alternatives to prolonged breast-
feeding and in long-term breast-fed children included in an
historical cohort without infant feeding intervention.
Methods
The ANRS 1202/1202 Ditrame Plus study was an open-
labeled cohort, based on patients attending community-run
health facilities in Abobo and Yopougon, the two most-
densely populated districts of Abidjan, the economic capital
of Co ˆte d’Ivoire. In this setting, HIV prevalence was around
11% among pregnant women in 2002 [13], municipal water is
of generally good quality [14], and breast-feeding is widely
practiced long term [15,16].
The Ditrame Plus study was granted ethical permission in
Co ˆte d’Ivoire from the ethical committee of the National
AIDS Control Programme, and in France from the institu-
tional review board of the French Agence Nationale de
Recherches sur le Sida (ANRS).
Inclusion Procedures and Research Design
The inclusion procedures and research design undertaken
in the Ditrame Plus study were described in detail in previous
publications [17,18]. Brieﬂy, from March 2001 to March 2003,
any pregnant woman aged 18 y and over, diagnosed as HIV
infected within one of the selected community-run health
facilities, was proposed for entry into the study.
Women included were systematically presented with both
peripartum antiretroviral and postpartum nutritional inter-
ventions to prevent mother-to-child transmission of HIV.
First, they received a short peripartum drug combination of
zidovudine with or without lamivudine and nevirapine single
dose [17]. Second, they were systematically and antenatally
proposed to practice either complete avoidance of breast-
feeding or exclusive breast-feeding with early cessation from
the fourth month. Replacement feeding from birth or from
breast-feeding cessation until 9 mo of age, as well as the
material needed, were provided free of charge. In all cases,
the staff supported the choice expressed by the women and
counseled them accordingly [18].
Follow-up Procedures and Data Collection
Two centers were exclusively dedicated to the follow-up of
the mother–infant pairs. From birth up to the second
birthday, 19 visits were scheduled on study sites for clinical,
nutritional, psychosocial, and biological follow-up of both
mothers and infants. Mother–infant pairs were seen at birth,
48 h after delivery, weekly until age 6 wk, monthly until age 9
mo, and every 3 mo until the second birthday. At each contact,
the medical staff documented clinical events that occurred in
children since the last visit. At each scheduled visit, infant
feeding practices were recorded via structured questionnaires
[19]. Patients who did not keep scheduled appointments were
traced and encouraged to return to the study sites.
At each scheduled visit, anthropometric measurements,
including height and weight, were taken by trained staff
according to standard procedures [20].
Infant feeding counseling was made available at study sites
whenever needed [18]. Children requiring intravenous treat-
ment were managed at the day-care hospital units linked to
the study sites. For life-threatening diseases or diseases
requiring overnight care, children were immediately referred
to the pediatric unit of the University Hospital of Yopougon.
All transport costs were reimbursed, and all care expenses
related to any clinical event were entirely supported by the
project.
Pediatric Diagnosis of HIV Infection
Blood samples were collected at day 2, weeks 4, 6, and 12,
and then every 3 mo until 18 mo of age or until 2 mo after
complete cessation of breast-feeding if the child was ever
breast-fed. A serology examination was systematically per-
formed at age 18 mo in all children. Pediatric HIV infection
was deﬁned as a positive RNA PCR at any age or positive HIV
serology if aged 18 mo or more [21]. HIV-infected children
received cotrimoxazole chemoprophylaxis from the time of
their HIV diagnosis.
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Special attention was given to the collection of data on
child morbidity potentially linked to inadequate infant
feeding practices: diarrhea, acute respiratory infections, or
malnutrition. During the study, all reports of potential
outcomes were referred for independent review and classi-
ﬁcation by an event documentation committee unaware of
the child’s feeding practices. This committee used all clinical
information available, including hospital records if the child
had been hospitalized. The following deﬁnitions were used to
validate morbidity. Diarrhea was deﬁned as the passage of
three or more loose or watery stools during a 24-h period for
at least 2 d, or any reported diarrhea associated with at least
one clinical sign of dehydration, or any reported diarrhea
requiring care and followed by at least a second consultation
for the same reason during a 72-h period. A diagnosis of acute
Table 1. Baseline Characteristics of Mother–Infant Pairs, According to the Feeding Group
Category Variable Ditrame Plus Cohort Study 2001–2005 Ditrame Trial 1995–1998
Short-Term
Breast-Fed
Group (n ¼ 262)
Formula-
Fed Group
(n ¼ 295)
p-Value
a Overall
(n ¼ 557)
Long-Term Breast-
Fed Group (n ¼ 219)
p-Value
b
Mothers at enrollment,
median (IQR)
Age at delivery 26 (22–30) 27 (23–31) 0.16 26 (23–30) 25 (22–29) 0.01
Education, n (%) No schooling 123 (47) 75 (25) ,0.001 198 (36) 89 (41) 0.29
Primary school 92 (35) 125 (42) — 217 (39) 84 (38) —
Secondary school
or higher
47 (18) 95 (33) — 142 (25) 46 (21) —
Lifestyle, n (%) Lives with partner 183 (70) 186 (63) 0.09 369 (66) Not available —
Lives with family 104 (40) 114 (39) 0.80 218 (39) Not available —
Lives with partner’s family 71 (27) 68 (23) 0.27 139 (26) Not available —
At least one cospouse 72 (27) 56 (19) 0.02 128 (23) Not available —
Employed in formal
economy sector
139 (53) 145 (49) 0.36 284 (51) Not available —
Lives in shared housing
c 193 (74) 174 (59) ,0.001 367 (66) Not available —
Electricity at home 254 (97) 285 (97) 0.82 539 (97) Not available —
Main water supply, n (%) Tap water with tap
inside home
61 (23) 113 (38) ,0.001 174 (31) Not available —
Tap water with tap
outside home
201 (77) 182 (62) — 383 (69) Not available —
Gravidity/Parity,
median (IQR)
History of pregnancies 3 (2–5) 3 (2–5) 0.26 3 (2–5) 3 (2–5) 0.11
Number of children alive 1 (0–2) 1 (0–2) 0.09 1 (0–2) 1 (1–3) 0.09
Anthropometry,
mean 6 SD
Maternal weight (kg) 64 6 10 64 6 10 0.77 64 6 10 61 6 8 ,0.01
Maternal height (cm) 160 6 6 160 6 6 0.84 160 6 61 6 0 6 6 0.23
Biological characteristics,
median (IQR)
Lymphocyte CD4 count
(cells/mm
3)
392 (265–340) 386 (239–583) 0.73 387 (249–562) 558 (329–753) ,0.001
Log10 HIV RNA viral load 4.2 (3.6–4.7) 4.3 (3.6–4.9) 0.11 4.3 (3.6–4.8) 4.0 (3.5–4.7) 0.05
WHO clinical stage, n (%) Stage 1 or 2 197 (75) 215 (72) 0.46 412 (74) 183 (84) ,0.001
Stage 3 65 (25) 77 (26) — 142 (25) 36 (16) —
Stage 4/AIDS 0 3 (1) — 3 (1) 0 —
Peripartum ARV
treatment, n (%)
Placebo 0 0 — 0 107 (49) —
sc ZDV 0 0 — 0 112 (51) —
sc ZDV þ sd NVP 174 (66) 196 (66) 0.99 370 (66) 0 —
sc ZDV þ sc 3TC þ sd NVP 88 (34) 99 (34) — 187 (34) 0 —
Infants characteristics Male, n (%) 138 (53) 147 (50) 0.50 285 (51) 111 (51) 0.79
Birth weight (g), mean 6 SD 3,000 6 445 2,959 6 470 0.28 2,970 6 478 2,871 6 418 ,0.01
Birth length (cm), mean 6 SD 49 6 2.3 49 6 2.5 0.28 49 6 2.5 48 6 2.4 0.10
Head circumference at
birth (cm), mean 6 SD
33 6 1.4 33 6 1.4 0.65 33 6 1.4 33 6 1.4 0.45
Low birth weight (,2,500 g), n (%) 24 (9) 40 (14) 0.11 64 (11) 33 (15) 0.16
Multiple birth outcome, n (%) 10 (4) 18 (6) 0.22 28 (5) 2 (1) ,0.01
Confirmed pediatric HIV
infection, n (%)
Acquired in peripartum 14 (5) 20 (7) 0.02 34 (6) 21 (9) ,0.001
Acquired in postpartum 13 (5) 3 (1) — 16 (3) 30 (14) —
ANRS 1201/1202 Ditrame Plus and ANRS 049 Ditrame studies, Abidjan, Co ˆte d’Ivoire, 1995–2005 (n ¼ 776).
aTest for difference between the early weaned breast-fed and formula-fed groups.
bTest for difference between the Ditrame and Ditrame Plus studies.
cShared housing consists of typical housing with several houses organized around a yard where inhabitants live in crowded accommodation and share kitchen and restroom.
ARV, antiretroviral; IQR, interquartile range; sc 3TC, short-course lamivudine; sc ZDV, short-course zidovudine; SD, standard deviation; sd NVP, nevirapine single dose.
doi:10.1371/journal.pmed.0040017.t001
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Morbidity, Mortality, and Infant Feedingrespiratory infection was made if the child presented a cough,
fever (axillary temperature greater than 37.5 8C), and focal
pulmonary ﬁndings on physical examination. A diagnosis of
malnutrition was considered when the child presented with
growth faltering (no change or a decrease in measurements
on growth charts from one visit to another) and was referred
to the nutritionists to receive appropriate nutritional care,
including provision of protein-enriched food.
In case of child death, verbal autopsies were systematically
conducted by trained psychosociologists to assign a possible
cause of death [22]. The potential contributing causes of
death were independently assessed by two pediatricians,
unaware of the child’s feeding practices, on the basis of all the
clinical information collected (including hospital records)
and the verbal autopsy. In case of conﬂicting diagnosis
between the two pediatricians, the opinion of a third one was
sought. Causes of death were codiﬁed using the 10th revision
of the International Statistical Classiﬁcation of Diseases and
Related Health Problems [23].
Study Outcomes
The primary outcome of the study was the 2-y occurrence
in children according to infant feeding practices and HIV
status of adverse health outcomes: any severe event (death, or
hospital admission related to any cause or in any location) or
validated morbid event as deﬁned above. The two compo-
nents of this deﬁnition were also investigated separately as
secondary outcomes (severe events and validated morbidity).
A secondary analysis was performed to compare the 18-mo
mortality among children exposed to alternatives to pro-
longed breast-feeding with the mortality of long-term breast-
fed children using the ANRS 049 Ditrame trial. This historical
trial was conducted in Abidjan, Co ˆte d’Ivoire, and Bobo-
Dioulasso, Burkina Faso, in 1995–1998, and it evaluated the
efﬁcacy of zidovudine to reduce mother-to-child transmission
of HIV [24,25]. For the present analysis, we have included
women from the Ditrame trial recruited in Co ˆte d’Ivoire only.
These women were recruited at the same sites and in the same
population as the Ditrame Plus study. No strategy was
proposed at that time to prevent the postnatal transmission
of HIV:infants were long-term breast-fed asthey usuallyare in
Abidjan [9].
Statistical Analysis
All live-born infants were available for analysis. In the case
of multiple births, only the ﬁrst born was included. Live-born
infants fed at least once were classiﬁed in either the breast-
fed or formula-fed group on the basis of the infant feeding
practices recorded at the visit 2 d after birth, i.e., according to
the feeding practice that had been actually initiated. Infants
who died or were lost to follow-up before having been fed at
least once were unclassiﬁed.
Baseline characteristics were compared between these two
groups using the Pearson v
2 test or the Fisher exact test to
compare categorical variables, and the Mann-Whitney U test
to compare continuous variables.
Compliance with the infant feeding choice was assessed
and deﬁned as follows: breast-feeding mothers were consid-
ered noncompliant if they had ceased breast-feeding before
the third month, and nonbreast-feeding mothers were
considered noncompliant if they had breast-fed at least once
over the study period. Total effective follow-up time ex-
pressed in person-years was compared to total expected
follow-up time in both groups. The causes reported for
stopping follow-up before the expected 24 mo were
described.
The cumulative probabilities of remaining free from an
adverse health outcome, a severe event or a validated morbid
event, were compared between short-term breast-fed and
formula-fed infants using time-to-failure methods, including
the Kaplan-Meier estimation and log-rank testing. Multi-
variate analysis used Cox proportional-hazard models. This
approach allowed for the estimation of HRs for mortality and
morbidity between the two groups, with adjustment for
pediatric HIV status (time-dependent variable) and other
covariates at baseline (maternal education, type of housing,
type of water supply, baseline maternal CD4 count, living or
not with one’s partner, study site, and low birth weight).
Incidence rates of diarrhea, acute respiratory infection, and
malnutrition were expressed per 100 person-year at risk,
according to infant feeding practices and HIV status.
Estimates were reported with their 95% conﬁdence intervals
(CIs).
All statistical analyses were carried out with the use of SAS
software (version 8.2; SAS Institute, http://www.sas.com).
Table 2. Follow-Up Characteristics among Breast-Fed and Formula-Fed Children
Group Initial Number
of Children
Follow-Up Over the
First 2 y of Life
Theoretical Follow-Up
a
(Person-Years)
Effective
Follow-Up
24 mo
Completed
24 mo Not
Completed
(Person-Years) Percentage of
Theoretical Follow-Up
Children
Deceased
Children Lost
to Follow-Up
Breast-fed children 262 185 18 59 498 421 85
Formula-fed children 295 226 21 48 562 517 92
Total 557
b 411 39 107 1,060 938 88
ANRS 1201/1202 Ditrame Plus study, Abidjan, Co ˆte d’Ivoire, 2001–2005 (N ¼ 557).
aTaking into account children deaths.
bAmong the 569 live-born infants included, 12 were not classified because they died in the first 72 h of life without having received any food or were los to follow-up before recording
information on first feed.
doi:10.1371/journal.pmed.0040017.t002
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The cohort proﬁle from acceptance of HIV testing to
enrollment in the Ditrame Plus study is described elsewhere
[17,18]. Among the 643 HIV-infected pregnant women
consecutively enrolled between March 2001 and March
2003, 19 with a nonconﬁrmed HIV-1 status, or infected with
HIV-2 only, were excluded, 44 were lost to follow-up before
delivery, and 580 gave birth to 612 children [18]. After
exclusion of second- and third-born babies of multiple births,
580 mother–infant pairs were included in the present
analysis. Of these, 11 (1.9%) were stillbirths, 11 (1.9%) died
within the ﬁrst 72 h of life without having received any food,
and one (0.2%) was lost to follow-up before recording
information on ﬁrst feed. Among the 557 live-born children
fed at least once, 295 (53%) constituted the formula-fed
group and 262 (47%) the short-term breast-fed group.
Baseline Study Population Characteristics
Baseline characteristics of mother–infant pairs in the
Ditrame Plus short-term breast-fed and formula-fed groups
are summarized in Table 1. Compared to breast-feeding
mothers, formula-feeding mothers had a signiﬁcantly higher
level of education, were less likely to have cospouses or live-in
typical shared housing, and were more likely to have tap
water access at home. The other sociodemographic, clinical,
and biological characteristics were comparable between the
two groups.
Compliance with the Initial Infant Feeding Maternal
Choice
In the breast-feeding group, 24 women (9%) were not
compliant with the nutritional intervention agreed upon with
the study team because they ceased breast-feeding before age
3 mo and switched to feeding their infants with artiﬁcial
Figure 1. Two-Year Probability of Remaining Free from Adverse Health Outcome (Hospitalization or Death or Validated Morbidity) According to the
Feeding Group and Pediatric HIV Status
ANRS 1201/1202 Ditrame Plus study, Abidjan, Co ˆte d’Ivoire, 2001–2005 (n ¼ 557).
doi:10.1371/journal.pmed.0040017.g001
PLoS Medicine | www.plosmedicine.org January 2007 | Volume 4 | Issue 1 | e17 0143
Morbidity, Mortality, and Infant Feedingfoods. Among the 262 breast-feeding mothers, complete
cessation of breast-feeding occurred a median of 4 mo after
delivery (interquartile range [IQR], 3–5 mo). In this group,
91% of the children were breast-fed for at least 3 mo, and
47% were still being breast-fed at age 6 mo. Women were
encouraged to practice exclusive breast-feeding, but they
failed; instead, most of the infants were predominantly
breast-fed during the ﬁrst 3 mo of life (i.e., children were
given small amounts of water or water-based drinks in
addition to breast milk) [18].
In the formula-feeding group, 44 women (15%) were
noncompliant because they were found to have practiced
breast-feeding at least once, 83% of them before their child
was 1 mo of age. They thereafter switched to predominant
breast-feeding.
Mother–Infant Pair Follow-up
Total follow-up time was 421 person-years among short-
term breast-fed children and 517 person-years among
formula-fed children, yielding, respectively, 85% and 92%
of expected follow-up times (Table 2). Follow-up was stopped
before age 24 mo for 107 children, accounting for 22% of the
breast-fed children and 16% of the formula-fed children (p¼
0.06). For these 107 lost-to-follow-up children, the median
age at the end of their observation time was 364 d (IQR, 92–
508 d), and was signiﬁcantly higher in formula-fed (415 d in
median, IQR, 260–547 d) than breast-fed children (245 d,
IQR, 42–456 d).
The reported causes for stopping follow-up before age 24
mo did not differ between the two groups and were as follows:
relocation outside the Abidjan limits (40%), refusal linked to
the study protocol (too many scheduled visits or blood
samples collected, 15%), family problems (mother ill or
deceased, child with the father outside Abidjan, or widow-
hood, 9%), fear of stigmatization linked to the study
participation (7%), and unspeciﬁed for the remainder (29%).
Occurrence of Adverse Health Outcomes
As shown in Figure 1, 37% of the formula-fed and 34% of
the short-term breast-fed children remained free from an
adverse health outcome, yielding an unadjusted HR among
formula-fed children compared to breast-fed children of 1.09
(95% CI, 0.87–1.35; p ¼ 0.43). After adjustment for pediatric
HIV status and baseline covariates described in Methods, this
HR was 1.10 (95% CI, 0.87–1.38, p ¼ 0.43).
In a multivariate analysis, the occurrence of an adverse
health outcome was only signiﬁcantly associated with the
diagnosis of pediatric HIV infection (HR, 3.1; 95% CI, 2.3–
4.1).
Occurrence of Severe Events
The overall 2-y probability of survival in the Ditrame Plus
study was 90%. Mortality rates did not differ signiﬁcantly
between short-term breast-fed and formula-fed children.
Over the 2-y period, short-term breast-fed and formula-fed
children were comparable for cause of death; however, the
frequency of diarrhea tended to be higher in formula-fed
children (p ¼ 0.10) (Table 3).
Among the 557 children, 75 died or were hospitalized: 39
were in the formula-fed group and 36 in the breast-fed group.
As detailed in Figure 2, the probability of remaining free
from hospitalization or death over the ﬁrst 2-y of life was the
same in the two groups, even after adjustment for potential
confounders. The unadjusted and adjusted HRs among
formula-fed children compared to short-term breast-fed
Table 3. Potential Contributing Causes of Death among Children According to the Feeding Group
Mortality Live-Born Children
(n ¼ 569)
Children Fed at Least Once (n ¼ 557)
Breast-Fed Group
(n ¼ 262)
Formula-Fed Group
(n ¼ 295)
Number of
child deaths
Total
a 50 18 21
Occurring in the early neonatal period 12 1 0
Occurring in the late neonatal period 1 0 1
Occurring between day 29 and day 732 37 17 20
Median age at death, in days (IQR)
b 119 (18–249) 136 (75–283) 204 (98–301)
Contributing causes
of death, n (%)
Bronchopneumonia 6 (12) 4 (22) 2 (9)
Diarrhea 9 (18) 2 (11) 7 (33)
Meningitis 4 (8) 2 (11) 2 (10)
Severe anemia 2 (4) 0 2 (10)
Respiratory failure 2 (4) 2 (11) 0
Tuberculosis 1 (2) 0 1 (4)
Measles 1 (2) 1 (6) 0
Zoster 1 (2) 1 (6) 0
Acute HIV infection syndrome 4 (8) 2 (11) 2 (10)
Perinatal condition
c 13 (26) 1 (6) 2 (10)
Undocumented origin 7 (14) 3 (16) 3 (14)
ANRS 1201/1202 Ditrame Plus study, Abidjan, Co ˆte d’Ivoire, 2001–2005 (N ¼ 569).
aTest for difference between the breast-fed and formula-fed groups: p ¼ 0.91.
bTest for difference between the breast-fed and formula-fed groups: p ¼ 0.39.
cIntrauterine hypoxia (n¼4), neonatal infection (n¼3), prematurity (n¼2), cord around neck (n¼1), congenital atresia of duodenum (n¼1), congenital atresia of bile ducts (n¼1), and
congenital hernia (n ¼ 1).
doi:10.1371/journal.pmed.0040017.t003
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Morbidity, Mortality, and Infant Feedingchildren were 0.89 (95% CI, 0.57–1.40; p¼0.62) and 1.19 (95%
CI, 0.75–1.91; p ¼ 0.44), respectively.
In a multivariate analysis, the occurrence of death or
hospitalization was signiﬁcantly associated with the diagnosis
of pediatric HIV infection (HR, 15.2; 95% CI, 9.4–24.6), low
birth weight (HR, 1.8; 95% CI, 1.1–3.3) and mother’s illiteracy
(HR, 2.0; 95% CI, 1.2–3.2), but not with infant’s mode of
feeding (HR, 1.2; 95% CI, 0.7–1.9). Very similar results were
obtained when performing this analysis among HIV-unin-
fected children alone.
Occurrence of Validated Morbidity
Over the 2-y period, 36% of the children remained free
from diarrhea, acute respiratory infection, or malnutrition
(Figure 3). This percentage was slightly higher in formula-fed
compared to short-term breast-fed children, but the differ-
ence never reached statistical signiﬁcance, even after adjust-
ment for potential confounders. The unadjusted and adjusted
HRs among formula-fed children compared to breast-fed
children were 1.15 (95% CI, 0.92–1.43; p¼0.22) and 1.16 (95%
CI, 0.92–1.46; p ¼ 0.21), respectively.
The incidence rates of diarrhea, acute respiratory infec-
tion, and malnutrition are reported in Table 4. Compared to
short-term breast-fed children, the incidences of diarrhea
and acute respiratory infection were higher among formula-
fed children (27 versus 22 cases and nine versus six cases per
100 person-years, respectively), yielding adjusted HRs of 1.4
and 1.7 (p ¼ 0.03 and p ¼ 0.04, respectively). The incidence of
malnutrition tended to be higher in breast-fed than formula-
fed children (14 versus 11 cases per 100 person-years), but this
difference was not statistically signiﬁcant, even after adjust-
ment.
Figure 2. Two-Year Probability of Remaining Free from Severe Events (Hospitalization or Death) According to the Feeding Group and Pediatric HIV
Status
ANRS 1201/1202 Ditrame Plus study, Abidjan, Co ˆte d’Ivoire, 2001–2005 (n ¼ 557).
doi:10.1371/journal.pmed.0040017.g002
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Morbidity, Mortality, and Infant FeedingComparison of Mortality Rates with Long-Term Breast-Fed
Infants
In 1995–1998, 240 women delivered 243 children in the
Abidjan site of the Ditrame trial. After exclusion of three
second-born babies of multiple births, four stillbirths, four
children who died within the ﬁrst 72 h of life without having
received any food, three lost to follow-up before recording
information on ﬁrst feed, and ten nonbreast-fed children, 219
long-term breast-fed children were included in the present
analysis.
Baseline characteristics of these mother–infant pairs are
presented in Table 1 and compared with the patients of the
Ditrame Plus study. Women used for historical comparison
were signiﬁcantly younger, had higher CD4 counts, and were
more likely to be at World Health Organization (WHO)
clinical stage 1–2, whereas their children had lower birth
weight than in the Ditrame Plus study.
The median duration of breast-feeding in the Ditrame trial
was 8 mo (IQR, 6–10 mo), and 80% of the children were still
being breast-fed at age 6 mo.
As detailed in Table 5, the overall 18-mo probability of
survival was signiﬁcantly higher in the Ditrame Plus study
than in the Ditrame trial: unadjusted HR of 2.24 (95% CI,
1.41–3.56; p , 0.001). But the 18-mo probability of survival
was similar among formula-fed and short-term and long-term
breast-fed HIV-uninfected children.
In a multivariate analysis, the occurrence of death was
signiﬁcantly associated with the diagnosis of pediatric HIV
infection (HR, 14.4; 95% CI, 8.5–25.5), low birth weight (HR,
1.9; 95% CI, 1.1–3.3), mother’s WHO clinical stage 3 (HR, 1.7;
95% CI, 1.1–2.9), mother’s illiteracy (HR, 1.7; 95% CI, 1.1–
2.8), but not with infant’s mode of feeding (long-term breast-
fed versus short-term breast-fed and formula-fed: HR, 1.3;
95% CI, 0.8–2.1).
Figure 3. Two-Year Probability of Remaining Free from Validated Morbidity (Diarrhea, Acute Respiratory Infection, or Malnutrition) According to the
Feeding Group and Pediatric HIV Status
ANRS 1201/1202 Ditrame Plus Study, Abidjan, Co ˆte d’Ivoire, 2001–2005 (n ¼ 557).
doi:10.1371/journal.pmed.0040017.g003
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In this large prospective cohort study, we found no
difference in 2-y rates of adverse health outcomes between
early weaned breast-fed and formula-fed children born to
HIV-infected mothers. Moreover, the 2-y probabilities of
remaining free from severe events (hospitalization or death)
and from morbidity validated by an independent committee
were comparable in these two groups. However, compared to
short-term breast-fed children and after adjustment for
potential confounders, the formula-fed ones had a slightly
increased risk of diarrhea or acute respiratory infections, but
this difference materialized into neither differences in
malnutrition rates nor hospitalization or death rates.
Another important issue was whether these two modiﬁed
infant feeding practices were safe as opposed to the standard,
more prolonged breast-feeding. For that purpose, we
compared 18-mo mortality among these short-term breast-
fed and formula-fed children with the mortality observed in
long-term breast-fed children within a historical trial
conducted in the same population. No excess in mortality
was observed in children exposed to alternatives to prolonged
breast-feeding when taking into account HIV status: an
overall 18-mo probability of survival of 96% was observed
among HIV-uninfected short-term and formula-fed children,
which was similar to the 95% probability observed in the
long-term breast-fed ones.
At ﬁrst glance, a randomized clinical trial allocating infant
feeding modalities at random would have been the ideal
design for investigating adverse health outcomes. We,
however, believe the way of feeding one’s forthcoming child
has to follow an informed and reasoned choice, and thus
depends on individual situations. The choice of the infant
feeding modality was thus left to the mother in a real-life
situation in which alternatives to prolonged breast-feeding
were available. The corollary of this nonrandomized design
was that breast-feeding women of the Ditrame Plus study
were different from those who did not breast-feed. The
comparison between the feeding groups could have thus been
biased by these differences. The breast-feeding group indeed
had lower maternal education, lived in more crowded
housing, and was less likely to have in-house access to tap
water. All of these factors could be expected to be associated
with greater morbidity and mortality in the breast-fed group,
but all our analyses adjusted for these potential confounders
to minimize this bias.
The Ditrame trial was used as a group of comparison
because no alternatives to prolonged breast-feeding had been
proposed within that study. The strength of this strategy was
that the women had been recruited at the same sites, with the
same criteria, and in the same population as the Ditrame Plus
study, and both of these studies were coordinated by the same
study group. Morbidity data had not been collected and
validated as in the Ditrame Plus study, however, limiting our
present analysis to mortality. Because the Ditrame trial and
the Ditrame Plus study were performed in the same setting by
the same team, we cannot exclude the possibility that the
medical team was less knowledgeable about managing infants
born to HIV-infected women in the earlier period of the
research program. We also acknowledge that there may have
been confounding factors that had not been taken into
account by our design, but we consider that the most
important ones were controlled for.
We had previously reported that the women included in
the Ditrame Plus cohort were representative of the general
population of pregnant women in Abidjan because they had
been prenatally recruited among all attendees of community-
run health facilities located in poor areas, with no other
selection criteria than being HIV infected and at least 18 y
old, and having accepted the study protocol [18]. All the
Table 4. Incidence Rates of Validated Morbidity According to the Feeding Group and Pediatric HIV Status
Validated Morbidity Diarrhea Acute Respiratory Infections Malnutrition
Breast-Fed
Group
Formula-Fed
Group
Breast-Fed
Group
Formula-Fed
Group
Breast-Fed
Group
Formula-Fed
Group
All children (N ¼ 557) Incidence rate per 100 person-years
(95% CI)
22 (18–26) 27 (23–31) 6 (4–9) 9 (6–12) 14 (10–18) 11 (8–14)
Events leading to: Day-care hospitalization, % 21 30 20 9 2 5
Overnight hospitalization, % 6 3 38 34 7 7
Mean number of days per
episode of hospitalization 6 SD
8.5 6 4.6 4.8 6 4.6 5.5 6 4.0 6.6 6 3.1 4.0 6 2.7 12.0 6 6.1
HIV-uninfected
children (n ¼ 507)
Incidence rate per 100 person-years
(95% CI)
22 (17–27) 26 (21–31) 5 (3–8) 8 (6–11) 12 (9–16) 9 (7–12)
HIV-infected
children (n ¼ 50)
Incidence rate per 100 person-years
(95% CI)
26 (12–47) 43 (23–74) 15 (6–33) 30 (14–57) 36 (20–60) 30 (14–57)
HR Overall unadjusted HR among
formula-fed children compared
to breast-fed children
1.28 (95% CI, 0.99–1.66), p ¼ 0.06 1.59 (95% CI, 0.98–2.58), p ¼ 0.06 0.72 (95% CI, 0.50–1.04), p ¼ 0.08
Overall adjusted HR among
formula-fed children compared
to breast-fed children
a
1.35 (95% CI, 1.03–1.76), p ¼ 0.03 1.68 (95% CI, 1.02–2.77), p ¼ 0.04 0.74 (95% CI, 0.50–1.08), p ¼ 0.12
ANRS 1201/1202 Ditrame Plus study, Abidjan, Co ˆte d’Ivoire, 2001–2005 (N ¼ 557).
aAdjusted for maternal education, type of housing, type of water supply, baseline maternal CD4 count, living or not with one’s partner, study site, low birth weight, and pediatric HIV
status (time-dependant variable) in a Cox regression model.
SD, standard deviation; HR, hazard ratio.
doi:10.1371/journal.pmed.0040017.t004
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Morbidity, Mortality, and Infant Feedingwomen included in the study had access to tap water. But
because two-thirds of them lived in typical shared housing,
the tap was mainly outside the home. It had been previously
reported that the quality of municipal water in Abidjan was
good, but that household water storage was a common
practice that contributed to contaminated drinking water
[14]. Within our study, women were encouraged to avoid
water storage, but one-third of them reported having given
stored water to their child [26]. Such a practice might have
had adverse consequences on infant health.
Emphasis was made in the study protocol on the quality of
follow-up of mother–infant pairs. Overall, 88% of the
expected follow-up had been completed, and lost-to-follow-
up children had participated in the study for a median of 1 y.
The reasons for stopping follow-up earlier than expected was
recorded for two-thirds of these women, which means that
they had come to study sites to explain their intent or that
they had been traced at home. In all cases, the vital status of
the child was recorded at this last contact. Most of these
women were unable to continue their study participation
because they moved outside Abidjan to return to the north
part of Co ˆte d’Ivoire or to their birth country (mainly Mali or
Burkina Faso), which might have been linked to the current
political crisis in Co ˆte d’Ivoire. As reported within another
study, the follow-up was better among nonbreast-feeding
mothers [12]. This could be explained by the mother’s
sociodemographic characteristics or the health care workers’
attitude toward this latter group, and could be a possible
source of bias [27].
Given the relatively high standard of care proposed within
our study (closed clinical follow-up adapted to the child’s age
with free provision of care), our primary outcome was the
occurrence of adverse health outcomes, deﬁned as morbidity,
hospitalization, or death. Emphasis was thus made on the
collection and validation of morbidity. The same criteria
were used for breast-fed and formula-fed children because
the event validation committee was blinded to the exact child
feeding practices. Because most of the women in our study
were illiterate, we have extended the WHO deﬁnition of
diarrhea to any diarrhea associated with dehydration or
requiring at least a second consultation for the same reason.
This may have contributed to a slightly overestimated
incidence of diarrhea.
Overall, we believe follow-up quality was high enough and
sufﬁciently unbiased so that estimates of the incidence of
adverse health outcomes are adequately made with the same
deﬁnitions in both groups.
When compared with the Ditrame trial in which no speciﬁc
infant feeding counseling was made available, the provision
of peripartum antiretroviral prophylaxis combined with the
promotion of two alternatives to prolonged breast-feeding
within Ditrame Plus considerably reduced the number of
HIV-infected children: mother-to-child transmission of HIV
was signiﬁcantly reduced with a long-term beneﬁt sustained
until age 18-mo. For instance, 18-mo HIV transmission rates
as low as 7% (95% CI, 4%–11%) and 6% (95% CI, 2%–10%)
were obtained in short-term breast-fed and formula-fed
children, respectively, whose mothers had received a peri-
partum short-course combination of zidovudine and 3TC in
addition to single-dose nevirapine [28]. In comparison, the
HIV transmission rate was 22% (95% CI, 16%–30%) at age 18
mo among the long-term breast-fed children of the Ditrame
trial. Moreover, the mortality among HIV-uninfected chil-
dren exposed to short-term breast-feeding or formula
feeding was similar to the mortality observed among long-
term breast-fed uninfected children. Hence, the overall
probability of survival was improved among early weaned
and formula-fed children in comparison to the long-term
breast-fed ones.
Given appropriate nutritional counseling and care, access
to clean water, and an adequate supply of breast-milk
substitutes, early weaning and formula feeding were not
harmful for infant health among HIV-exposed children.
Given these constraints, these alternatives to prolonged
breast-feeding were not only safe, but socially acceptable
and feasible within our population-based study. These results
need to be balanced with the evaluation of other outcomes
such as the assessment of child growth according to infant
feeding practices and maternal perceptions of stigma given
different infant feeding strategies.
Table 5. The 18-Mo Probability of Survival (95% CI) According to the Feeding Group and Pediatric HIV Status
Trial Infant Feeding Group Age 3 mo Age 6 mo Age 12 mo Age 18 mo p-Value
a,b
Ditrame Plus cohort (2001–2005):
short-term breast-fed children
All (n ¼ 262) 0.97 (0.94–0.99) 0.95 (0.92–0.97) 0.94 (0.91–0.97) 0.92 (0.89–0.96) p1 ¼ 0.90
HIV-uninfected children (n ¼ 235) 0.97 (0.95–0.99) 0.97 (0.95–0.99) 0.96 (0.94–0.99) 0.96 (0.94–0.99) p2 ¼ 0.83
HIV-infected children (n ¼ 27) 0.92 (0.83–0.99) 0.78 (0.62–0.93) 0.73 (0.57–0.90) 0.61 (0.43–0.80) p3 ¼ 0.61
Ditrame Plus cohort (2001–2005):
formula-fed children
All (n ¼ 295) 0.97 (0.96–0.99) 0.97 (0.94–0.99) 0.94 (0.91–0.97) 0.93 (0.90–0.96) —
HIV-uninfected children (n ¼ 272) 0.98 (0.96–0.99) 0.98 (0.96–0.99) 0.98 (0.96–0.99) 0.96 (0.93–0.98) —
HIV-infected children (n ¼ 23) 0.91 (0.79–0.99) 0.78 (0.61–0.95) 0.56 (0.36–0.77) 0.56 (0.36–0.77) —
Ditrame trial (1995–1998):
long-term breast-fed children
All (n ¼ 219) 0.98 (0.96–0.99) 0.93 (0.89–0.96) 0.86 (0.82–0.91) 0.83 (0.78–0.89) p4 , 0.001
HIV-uninfected children (n ¼ 168) 0.98 (0.96–0.99) 0.98 (0.96–0.99) 0.97 (0.94–0.99) 0.95 (0.92–0.98) p5 ¼ 0.79
HIV-infected children (n ¼ 51) 0.98 (0.94–0.99) 0.77 (0.66–0.89) 0.52 (0.37–0.66) 0.45 (0.30–0.69) p6 ¼ 0.25
ANRS 1201/1202 Ditrame Plus and ANRS 049 Ditrame studies, Abidjan, Co ˆte d’Ivoire, 1995–2005 (N ¼ 776).
aTest for difference between the short-term breast-fed and formula-fed groups (log-rank): overall (p1), among HIV-uninfected children (p2), and among HIV-infected children (p3).
bTest for difference between the long-term breast-fed group and the short-term breast-fed and formula-fed groups pooled together (log-rank): overall (p4), among HIV-uninfected
children (p5), and among HIV-infected children (p6).
doi:10.1371/journal.pmed.0040017.t005
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Morbidity, Mortality, and Infant FeedingThese ﬁndings of the Ditrame Plus study are consistent
with a previous clinical trial of randomly allocated infant
feeding practices in Kenya, with the preliminary results of a
cohort study in Uganda and with a large African pooled
analysis [12,29,30]. However, these ﬁndings differ from
operational research suggesting that formula feeding was
associated with higher mortality, morbidity, and stigma in
ﬁeld settings [31,32]. More recently, a clinical trial conducted
in Botswana allocated at random 6 mo of breast-feeding plus
prophylactic infant zidovudine, or formula feeding plus 1 mo
of zidovudine [33]. In that trial, the probability of infant
death by month 7 was signiﬁcantly higher in the formula-fed
group than in the breast-fed group (9.3% versus 4.9%; p ¼
0.003), but this difference diminished beyond month 7, such
that the time-to-mortality distributions through 18 mo of age
were not signiﬁcantly different (10.7% versus 8.5%; p¼0.21).
The access to care, support, and counseling, the provision
of the breast-milk substitutes, and the clean water availability,
as well as the good follow-up observed within the Ditrame
Plus study, would all be expected to lead to more optimal
outcomes for alternatives to prolonged breast-feeding in
contrast to what was observed in less well-structured or well-
supported programs. However, the clean water access, the
education level of the mothers, and the economic status of
the families included in our cohort appear representative of
many urban settings in Africa and lead to a cautious but
possible generalization of our results to contexts with
appropriate political and structural supports.
In conclusion, we urge the operational implementation in
urban African settings of programs aimed at the overall
reduction of mother-to-child transmission of HIV. HIV-
infected pregnant women could be offered several alter-
natives to prolonged and predominant breast-feeding so that
they could ﬁnd the one adapted to their individual situation:
either complete avoidance of breast-feeding or exclusive
breast-feeding with early cessation. The recent rollout in
Africa of programs of access to care for people living with
HIV could provide a unique opportunity to routinely
implement these infant feeding strategies. Both women and
children could be given appropriate nutritional counseling
and care within these initiatives. Moreover, the clinical
support available in such infrastructures could contribute
to minimizing infant mortality. The place of heavily
subsidized breast-milk substitutes within these programs
should, however, be politically discussed. At the same time,
more research is needed to improve on safe infant feeding
options for resource-constrained settings.
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Background. The HIV virus can be transmitted from infected mothers to
their babies during pregnancy and birth as well as after birth through
breast milk. Mother-to-child transmission in developed countries has
been all but eliminated by treatment of mothers with the best available
combination of antiretroviral drugs and by asking them to avoid breast-
feeding. However, in many developing countries, the best drug
treatments are not available to mothers. Moreover, breast-feeding is
generally the best nutritional choice for infants, especially in areas where
resources such as clean water, formula feed, and provision of healthcare
are scarce. And even if formula feed is available, formula-fed babies
might be at higher risk of dying from diarrhea and chest infections,
which are more common in infants who are not breast-fed. International
guidelines say that HIV-positive mothers should avoid all breast-feeding
and adopt formula feeding instead if this option is practical and safe for
them, which would require that they can afford formula feed and have
easy access to clean water. If formula-feeding is not feasible, guidelines
recommend that mothers should breast-feed only for the first few
months and then stop and switch the baby to solid food. One of these
two alternative options should be feasible in most African cities if
mothers are given the right support.
Why Was This Study Done? Several completed and ongoing studies are
assessing the relative risks and benefits of the two recommended
strategies for different developing country locations, and this is one of
them. The study, the ‘‘Ditrame Plus’’ trial by researchers from France and
Co ˆte d’Ivoire, was conducted in Abidjan, an urban West African setting.
The goal was to compare death rates and rates of certain diseases (such
as diarrhea and chest infections) between babies born to HIV-positive
mothers that were formula-fed and those that were breast-fed for a short
time after birth.
What Did the Researchers Do and Find? HIV-positive pregnant women
were invited to enter the study, and they received short-term drug
treatments intended to reduce the risk of HIV transmission to their
babies. Women in the trial were then asked to choose one of the two
feeding options and offered support and counseling for either one. This
support included free formula, transport, and healthcare provision.
Babies were followed up to their second birthday, and data were
collected on death rates and any serious illnesses. A total of 643 women
were enrolled into the study, and safety data were collected for 557
babies, of whom 295 were in the formula group and 262 were in the
short-term breast-feeding group. The researchers corrected for HIV
infection in the babies and found no evidence that the risk of other
negative health outcomes and death rates was any different between
the formula-fed babies and short-term breast-fed babies. Looking
specifically at individual diseases, the researchers found that the risks
for diarrhea and chest infections were slightly higher among formula-fed
babies, but this did not translate into a greater risk of death or worse
overall health. They also compared the death rates in this study with
some historical data from a previous research project done in the same
area on children born to HIV-positive mothers who had practiced long-
term breast-feeding. The mother-to-child transmission rate of HIV had
been much higher in that earlier trial, but looking only at the HIV-
negative children, the researchers found no difference in risk for death or
serious disease between the formula-fed or short-term breast-fed babies
from the Ditrame Plus trial and the long-term breast-fed babies from the
earlier trial.
What Do These Findings Mean? This study shows that if HIV-positive
mothers are well supported, either of the two feeding options currently
recommended (formula-only feed, or short-term breast-feeding) are
likely to be equivalent in terms of the baby’s chances for survival and
health. However, women in this study were offered a great deal of
support and the findings may not necessarily apply to real-life situations
in other settings in Africa, or outside the context of a research project. In
addition to routine care after birth, access to better drugs to prevent
mother-to-child transmission in developing countries remains an
important goal.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/doi:10.1371/journal.pmed.
0040017.
  Resources from Avert (an AIDS charity) on HIV and infant feeding.
  Information from the US Centers for Disease Control on mother-to-
child transmission of HIV
  Guidelines from the World Health Organization on mother-to-child
transmission of HIV
  AIDSMap pages on breast-feeding and HIV
  HIV Care and PMTCT in Resource-Limited Setting contains monthly
bulletins and a database devoted to HIV/AIDS infections and
prevention of the mother-to-child transmission of HIV
  The Ghent group is a network of researchers and policymakers in the
area of prevention of mother-to-child transmission of HIV
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